Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition will regularly stop breathing during sleep as the muscles in their ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage ...

The weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea ...

A new drug could put an end to cumbersome CPAP machines, which are thought to be used by some 33 million Americans to manage their sleep apnea. Roughly 39 million Americans, including President Biden, ...

There is currently no drug that treats sleep apnea. However, the third clinical trial of AD109 suggests there could be one in the future. Taylor Leamey wrote about all things wellness for CNET, ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

Read full article: New policy proposal would give stability for Nassau County students facing crises, allowing them to remain in school Read full article: Traffic Alert: RV fire shuts down 2 right ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

An existing drug has shown it can significantly improve the quality of sleep for those suffering from obstructive sleep apnea (OSA), so much so that many trial participants were able to hang up their ...

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight loss drug Zepbound and ...